NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that it has expanded its proteomics research products offerings through the acquisition of the Seppro affinity depletion technology and a library of 700 avian-derived antibodies from GenWay Biotech.
The Seppro products enable scientists to measure more precisely the expression of protein biomarkers from a range of mammalian and plant biological samples, said Sigma. The technology allows researchers to detect and analyze commonly obscured biomarkers in samples by removing highly abundant proteins.
The acquisition includes current inventory, production technology, and all future rights to produce and distribute the product lines, said Sigma. It adds to the firm’s current depletion product offerings, such as its ProteoPrep kits for the removal of highly abundant proteins from human serum and plasma.
The St. Louis-based firm said that the library of 700 polyclonal IgY antibodies acquired from San Diego-based GenWay marks its first IgY antibody offering.
Further terms of the acquisition were not provided.